DRTS · NASDAQ · Biotechnology

Alpha Tau Medical (DRTS)

Develops Alpha DaRT, a localized alpha-radiation therapy for solid tumors.

$15.19
vs last close−0.31 (−2.02%)

13F · 13D/G · Form 4

Institutions9.04%7.95M ADS
80 holders · as of Jun 30, 2026
Insiders17.87%15.73M ADS
9 holders · as of Aug 25, 2026
Other73.09%64.33M ADS
remainder

88.01M ADS as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Uzi Sofer1,2Insiderdirector, officer: Chief Executive Officer
15.57%13.70M ordinaryfiled Jun 30, 2025
Michael AvruchInsiderdirector
1.79%1.57M ordinaryfiled Mar 18, 2026
Gem Investment Advisors, LLCInstitution
1.63%1.43M ADSas of Jun 30, 2026
Hightower Advisors, LLCInstitution
0.99%874,994 ADSas of Jun 30, 2026
Boothbay Fund Management, LLCInstitution
0.88%773,481 ADSas of Jun 30, 2026
Aquamarine Financial (Cayman) LtdInstitution
0.82%721,501 ADSas of Jun 30, 2026
Pier Capital, LLCInstitution
0.79%691,939 ADSas of Jun 30, 2026
UBS Group AGInstitution
0.73%642,263 ADSas of Jun 30, 2026
Apella Capital, LLCInstitution
0.43%382,284 ADSas of Jun 30, 2026
Ark Investment Management LLCInstitution
0.31%277,086 ADSas of Jun 30, 2026
Polen Capital Management LLCInstitution
0.25%220,751 ADSas of Jun 30, 2026
Colony Group, LLCInstitution
0.21%184,726 ADSas of Jun 30, 2026
Mariner, LLCInstitution
0.19%167,086 ADSas of Jun 30, 2026
S. Morry BlumenfeldInsiderdirector
0.18%155,771 ordinaryfiled Mar 18, 2026
Daytona Street Capital LLCInstitution
0.17%146,106 ADSas of Jun 30, 2026
Kovitz Investment Group Partners, LLCInstitution
0.15%135,017 ADSas of Jun 30, 2026
Levin Capital Strategies, L.P.Institution
0.15%128,594 ADSas of Jun 30, 2026
David Mark MilchInsiderdirector
0.13%118,110 ordinaryfiled Mar 18, 2026
Wells Fargo & Company/MNInstitution
0.12%105,850 ADSas of Jun 30, 2026
Jane Street Group, LLCInstitution
0.10%91,145 ADSas of Jun 30, 2026
Raphi LevyInsiderofficer: Chief Financial Officer
0.10%90,180 ordinaryfiled Aug 25, 2026
Citadel Advisors LLCInstitution
0.07%61,559 ADSas of Jun 30, 2026
Dauntless Investment Group, LLCInstitution
0.07%61,200 ADSas of Jun 30, 2026
Susquehanna International Group, LLPInstitution
0.06%54,767 ADSas of Jun 30, 2026
Alan AdlerInsiderdirector
0.06%54,367 ordinaryfiled Mar 18, 2026
  1. Uzi Sofer's transaction reports restate only vehicles that traded; the 2025 ownership statement (13.70M) is used instead.
  2. Uzi Sofer reports a block also reported by Michael Avruch; it is counted once, under Michael Avruch.

13F, as of Jun 30, 2026

80 holders · 7.95M shares · 27 new positions · 45 increased · 10 reduced · 6 closed

HolderShares% outstandingChg q/qFiled
Gem Investment Advisors, LLC1.43M1.63%+1.32MAug 11, 2026
Hightower Advisors, LLC875.0K0.99%0Aug 5, 2026
Boothbay Fund Management, LLC773.5K0.88%+773.5KnewAug 14, 2026
Aquamarine Financial (Cayman) Ltd721.5K0.82%0Aug 12, 2026
Pier Capital, LLC691.9K0.79%+691.9KnewAug 5, 2026
UBS Group AG642.3K0.73%+355.6KAug 13, 2026
Apella Capital, LLC382.3K0.43%0Jul 8, 2026
Ark Investment Management LLC277.1K0.31%−15.0KAug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Oramed Pharmaceuticals Inc.incl. Oramed Ltd.19.99%14.11M13DMay 1, 2025
Uzi Sofer15.80%13.70M13GJul 24, 2025

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 21, 2026
Raphi Levyofficer: Chief Financial Officer
Sale2,871$15.0090,180
Aug 11, 2026
Raphi Levyofficer: Chief Financial Officer
Sale17,730$14.0090,180
Jul 6, 2026
Raphi Levyofficer: Chief Financial Officer
Sale2,270$14.0090,180
Jul 2, 2026
Raphi Levyofficer: Chief Financial Officer
Sale17,873$13.0090,180
Jul 1, 2026
Raphi Levyofficer: Chief Financial Officer
Sale2,127$13.0290,180
Jun 30, 2026
Raphi Levyofficer: Chief Financial Officer
Sale20,000$12.0090,180
Jun 25, 2026
Raphi Levyofficer: Chief Financial Officer
Sale · 2 lots20,000$11.00110,180
Jun 23, 2026
Raphi Levyofficer: Chief Financial Officer
Sale · 2 lots17,500$9.55130,180
Jun 3, 2026
Raphi Levyofficer: Chief Financial Officer
Sale · 2 lots32,500$10.83147,680

House and Senate disclosures

Not reported.